{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:07:53Z","timestamp":1775588873870,"version":"3.50.1"},"reference-count":12,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.4103\/ijn.ijn_73_22","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T14:59:38Z","timestamp":1669042778000},"page":"40","source":"Crossref","is-referenced-by-count":1,"title":["Low- versus high-dose cyclophosphamide in class III\/IV lupus nephritis: A retrospective study from South Asia"],"prefix":"10.25259","volume":"33","author":[{"given":"DilushiRowena","family":"Wijayaratne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"InoshiGunetilleke","family":"Atukorala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NalikaS","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DevasmithaA","family":"Wijesundara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RushikaDinal","family":"Lanerolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.371487-1","first-page":"711","article-title":"Clinical features and outcome of systemic lupus erythematosus","author":"Agarwal","year":"2009","journal-title":"Indian Pediatr"},{"key":"key-10.4103\/0971-4065.371487-2","first-page":"100","article-title":"Lupus nepritis in Asia: Clincal features and management","author":"Desmond","year":"2015","journal-title":"Kidney Dis"},{"key":"key-10.4103\/0971-4065.371487-3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-4065.371487-4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"key-10.4103\/0971-4065.371487-5","first-page":"2121\u201331","article-title":"Immunosuppressive therapy in lupus nephritis: The Euro-Lupus nephritis trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0971-4065.371487-6","first-page":"i67","article-title":"The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus","author":"Lewis","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.4103\/0971-4065.371487-7","first-page":"e9408","article-title":"Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis","author":"Ming","year":"2017","journal-title":"Medicine"},{"key":"key-10.4103\/0971-4065.371487-8","first-page":"S1","article-title":"Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: Low versus standard dose","author":"Castro-Santana","year":"2010","journal-title":"Ethn Dis"},{"key":"key-10.4103\/0971-4065.371487-9","first-page":"51","article-title":"How to calculate sample size in randomized controlled trial","author":"Zhong","year":"2009","journal-title":"J Thorac Dis"},{"key":"key-10.4103\/0971-4065.371487-10","first-page":"3096\u2013104","article-title":"Treatment of lupus nephritis with abatacept: The abatacept and cyclophosphamide combination efficacy and safety study","author":"ACCESS","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"key-10.4103\/0971-4065.371487-11","first-page":"557\u201368","article-title":"Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: A single center study","author":"Mehra","year":"2018","journal-title":"Rheumatol Int"},{"key":"key-10.4103\/0971-4065.371487-12","first-page":"61\u20134","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis trial comparing low-dose and high-dose intravenous cyclophosphamide","author":"Houssiau","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:49:15Z","timestamp":1712173755000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/low-versus-high-dose-cyclophosphamide-in-class-iii-iv-lupus-nephritis-a-retrospective-study-from-south-asia\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["371487"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_73_22","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}